【24h】

VITRIFICATION SOLUTIONS FOR THE CRYOPRESERVATION OF TISSUE-ENGINEERED BONE

机译:冻干组织工程化骨的玻璃化溶液

获取原文
获取原文并翻译 | 示例

摘要

Osteoblast (OB)-seeded hydroxyapatite (HA) scaffold cortical bone substitutes are being developed at Michigan State University. Preservation methods need to be developed to preserve such living products to ensure a steady supply for transplantation. Theoretically vitrification is an attractive method for the cryopreservation of tissue-engineered bone because it can eliminate the destructive effect of ice formation. However, relatively fast cooling and warming rates are required to avoid damage associated with ice crystallization and relatively high concentrations of cryoprotective agents (CPAs) are required to achieve a glassy (vitrified) state. These rapid rates of temperature change may not be possible as tissue-engineered structures become larger. In addition to cell damage, rapid rates may also cause destructive thermo mechanical damage to the scaffold itself. Slower rates can be used to achieve the vitrified state but this requires higher CPA concentrations, which are more toxic. As a means of studying the interactive determinants of an optimal vitrification process for osteoblasts, we have undertaken thermal analysis of a variety of vitrification solutions of interest using differential scanning calorimetry (DSC) to determine the critical cooling and warming rates. The toxicity dynamics and tendency for the scaffolds to be damaged mechanically by the vitrification process are also examined. Glycerol and dimethyl sulfoxide at a concentration of 40% were studied with and without an ice blocker. Two vitrification "cocktails" (VS55 and VEG) over a concentration range of 80% to 100% were studied with and without an ice blocker. On the basis of these studies 95% VEG with ice blocker was least toxic and yielded the highest recovery (~90%) for OBs vitrified in liquid suspension. Vitrification does not seem to be detrimental to the bending strength of high density (low porosity) HA scaffolds, but lower density HA scaffolds break more easily after vitrification in some instances.
机译:密歇根州立大学正在开发成骨细胞(OB)种植的羟基磷灰石(HA)支架皮质骨替代物。需要开发保存方法来保存这些活的产品,以确保稳定的移植供应。从理论上讲,玻璃化是一种用于冷冻保存组织工程骨骼的方法,因为它可以消除冰的破坏作用。然而,需要相对较快的冷却和升温速率以避免与冰结晶相关的损害,并且需要相对较高浓度的冷冻保护剂(CPA)以达到玻璃态(玻璃化)状态。随着组织工程结构的变大,这些快速的温度变化速率可能是不可能的。除细胞损伤外,快速反应还可能对支架本身造成破坏性的热机械损伤。可以使用较低的速率来达到玻璃化状态,但这需要更高的CPA浓度,而CPA的毒性更大。作为研究成骨细胞最佳玻璃化过程的相互作用决定因素的一种手段,我们使用差示扫描量热法(DSC)对各种感兴趣的玻璃化溶液进行了热分析,以确定临界的冷却和升温速率。还检查了毒性动力学和支架被玻璃化过程机械损坏的趋势。在有和没有阻冰剂的情况下,研究了浓度为40%的甘油和二甲基亚砜。在有和没有阻冰剂的情况下,研究了两种浓度为80%至100%的玻璃化“鸡尾酒”(VS55和VEG)。根据这些研究,含冰阻滞剂的95%VEG毒性最低,液体悬浮液中玻璃化的OB回收率最高(约90%)。玻璃化似乎对高密度(低孔隙率)HA支架的抗弯强度无害,但在某些情况下,玻璃化后密度较低的HA支架更容易断裂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号